Health TrialsbyHealthPanel

Post-COVID / Long-COVID

2

Review clinical trials related to Post-COVID / Long-COVID. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID)

This placebo-controlled, randomized, blinded, two-arm phase II study will test the safety and potential efficacy of the targeted mAb, Sipavibart (formerly AZD3152) in patients with Long COVID.

Participants needed: 100
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Nancy KlimasUpdated: Sep 29, 2026Locations: 1
Eligibility criteria

18 to 70 years old, [+7]

Known active acute SARS-CoV-2 infection ≤ 4 weeks from consent. [+43]

Read more
Status: Recruiting

Effects of Hydrotherapy During Post-COVID-19 Rehabilitation

This randomized controlled study evaluates the effects of cold water hydrotherapy as an adjunct to standard rehabilitation in patients with Post-COVID Syndrome. The primary aim is to assess changes in quality of life compared to standard rehabilitation alone.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Schön Klinik Berchtesgadener LandUpdated: Aug 28, 2025Locations: 1
Eligibility criteria

Diagnosis of Post-COVID Syndrome (ICD-10 code: U08.9) [+4]

Existing contraindications for Kneipp hydrotherapy like severe cardiovascular di... [+1]

Read more